Supplemental Balance Sheet and Cash Flow Information - Changes in Carrying Amount of Goodwill (Details) - USD ($) $ in Thousands |
12 Months Ended | |
|---|---|---|
Jun. 30, 2022 |
Jun. 30, 2021 |
|
| Beginning balance | $ 843,067 | $ 728,310 |
| Acquisitions | 102,818 | |
| Acquisitions | (4,407) | |
| Eminence impairment | (8,275) | |
| Currency translation | (8,284) | 11,939 |
| Ending balance | 822,101 | 843,067 |
| Protein Sciences [Member] | ||
| Beginning balance | 392,717 | 373,081 |
| Acquisitions | 7,848 | |
| Eminence impairment | (8,275) | |
| Currency translation | (7,949) | 11,788 |
| Ending balance | 376,493 | 392,717 |
| Diagnostics and Genomics [Member] | ||
| Beginning balance | 450,350 | 355,229 |
| Acquisitions | 94,970 | |
| Acquisitions | (4,407) | |
| Currency translation | (335) | 151 |
| Ending balance | $ 445,608 | $ 450,350 |
| X | ||||||||||
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount after tax of loss recognized that results from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. No definition available.
|
| X | ||||||||||
- Definition Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|